LetterLetter
Rheumatoid Arthritis Known HLA Associations are Unlikely To Be Associated With Atopic Dermatitis
David J. Margolis, Nandita Mitra and Dimitri S. Monos
The Journal of Rheumatology October 2020, jrheum.200583; DOI: https://doi.org/10.3899/jrheum.200583
David J. Margolis
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania; Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. This work was supported in part by grants from the National Institutes for Health (NIAMS) R01-AR060962 (PI: Margolis) and R01-AR070873 (MPI: Margolis/Monos). The Pediatric Eczema Elective Registry (PEER) study is funded as the Atopic Dermatitis Registry by Valeant Pharmaceuticals International (PI: Margolis). D.J. Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and serves on an advisory board for the National Eczema Association. D.S. Monos is Chair of the Scientific Advisory Board of Omixon, and owns options in and receives royalties from Omixon. Address correspondence to Dr. D.J. Margolis, MD, PhD, 901 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA. Email: margo@pennmedicine.upenn.edu.
Nandita Mitra
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania; Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. This work was supported in part by grants from the National Institutes for Health (NIAMS) R01-AR060962 (PI: Margolis) and R01-AR070873 (MPI: Margolis/Monos). The Pediatric Eczema Elective Registry (PEER) study is funded as the Atopic Dermatitis Registry by Valeant Pharmaceuticals International (PI: Margolis). D.J. Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and serves on an advisory board for the National Eczema Association. D.S. Monos is Chair of the Scientific Advisory Board of Omixon, and owns options in and receives royalties from Omixon. Address correspondence to Dr. D.J. Margolis, MD, PhD, 901 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA. Email: margo@pennmedicine.upenn.edu.
Dimitri S. Monos
Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania; Department of Pathology and Laboratory Medicine, Children’s Hospital of Philadelphia; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. This work was supported in part by grants from the National Institutes for Health (NIAMS) R01-AR060962 (PI: Margolis) and R01-AR070873 (MPI: Margolis/Monos). The Pediatric Eczema Elective Registry (PEER) study is funded as the Atopic Dermatitis Registry by Valeant Pharmaceuticals International (PI: Margolis). D.J. Margolis is or recently has been a consultant for Pfizer, Leo, and Sanofi with respect to studies of atopic dermatitis and serves on an advisory board for the National Eczema Association. D.S. Monos is Chair of the Scientific Advisory Board of Omixon, and owns options in and receives royalties from Omixon. Address correspondence to Dr. D.J. Margolis, MD, PhD, 901 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA. Email: margo@pennmedicine.upenn.edu.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Rheumatoid Arthritis Known HLA Associations are Unlikely To Be Associated With Atopic Dermatitis
David J. Margolis, Nandita Mitra, Dimitri S. Monos
The Journal of Rheumatology Oct 2020, jrheum.200583; DOI: 10.3899/jrheum.200583